Please wait a minute...
European Journal of Gynaecological Oncology  2018, Vol. 39 Issue (3): 485-487    DOI: 10.12892/ejgo3884.2018
Case Report Previous articles | Next articles
Isolated recurrence of early-stage cervical cancer in the abdominal wall with suboptimal surgery
E. Yilmaz1, *(), E. I. Coskun1, C. Koc2, N. Sahin3, B. Isik2, B. Ciplak1
1 Inonu University Turgut Ozal Medical Center Obstetrics and Gynecology Department, Malatya, Turkey
2 Inonu University Turgut Ozal Medical Center General Surgery Department, Malatya, Turkey
3 Inonu University Turgut Ozal Medical Center Pathology Department, Malatya, Turkey
Download:  PDF(236KB)  ( 63 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
In this report, the authors present the case of a 47-year-old woman with an isolated recurrence of early-stage cervical cancer treated with suboptimal surgery of the abdominal wall and that subsequently underwent radiotherapy.
Key words:  Cervix      Cancer      Recurrence      Hysterectomy      Abdominal wall     
Published:  10 June 2018     
*Corresponding Author(s):  ERCAN YILMAZ     E-mail:  ercanyilmazgyn@yahoo.com

Cite this article: 

E. Yilmaz, E. I. Coskun, C. Koc, N. Sahin, B. Isik, B. Ciplak. Isolated recurrence of early-stage cervical cancer in the abdominal wall with suboptimal surgery. European Journal of Gynaecological Oncology, 2018, 39(3): 485-487.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo3884.2018     OR     https://ejgo.imrpress.com/EN/Y2018/V39/I3/485

[1] Xiao-Peng Yu, Cai-Gang Liu, Fang Qiu, Fei Xing, Si-Jia Han, Ye Han, Gui-Jin He. Breast cancer overall-survival can be predicted with a 19 lncRNA tissue signature[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 838-843.
[2] Plotti Francesco, Bartolone Martina, Terranova Corrado, Guzzo Federica, De Cicco Nardone Carlo, Montera Roberto, Molinaro Michele, Ciccozzi Massimo, Benvenuto Domenico, Di Donato Violante, Benedetti Panici Pierluigi, Angioli Roberto. Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 844-849.
[3] Burak Tatar. Risk of nodal metastasis associated with lymphovascular space invasion in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 850-854.
[4] Seda Yuksel Simsek, Ozan Cem Guler, Gülşen Doğan Durdag, Sezin Yüce Sari, Melis Gultekin, Ferah Yildiz, Husnu Celik, Gurcan Erbay, Huseyin Cem Onal. The clinical outcomes of ovarian cancer in patients with brain metastasis[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 881-886.
[5] Jaswinder Chalia, Musse Hussein, Mariya Farooqui, Jordan Mattson, Sally A. Mullany, Molly E. Klein, Boris Winterhoff, Mahmoud A. Khalifa. Concurrent immunohistochemical testing of L1CAM and MMR proteins adds value in risk stratification of endometrial cancer: a proof of concept[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 887-892.
[6] Yumiko Goto, Yoshie Kametani, Aurélie Auguste, Thuraya Almamari, Audrey LeFormal, Shun-ichiro Izumi, Catherine Genestie, Hitoshi Ishimoto, Mikio Mikami, Alexandra Leary. Tropomyosin-related kinase B (TrkB) full-length isoform is related to advanced-stage clear cell ovarian cancer (CCOC)[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 899-908.
[7] Luibov.I. Korolenkova, Ivan.S. Stilidi, Inna.N. Lazareva. Diagnostic value of colposcopy for cervical intraepithelial neoplasia 2–3/carcinoma in situ and microinvasive cervical cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 909-916.
[8] Kelly Baillie, Nicholas Reed, Jiafeng Pan, Jennifer Laskey, Marion Bennie, Christine Crearie, Tanja Mueller, Kimberley Kavanagh, Nadeem Siddiqui, Kevin Burton, John Telfer, Rhona Lindsay, Smruta Shanbhag, Rosie Harrand, Azmat Sadozye, Kathryn Graham. Retrospective cohort study of neoadjuvant chemotherapy followed by tailored surgery in locally advanced sphincter-threatening vulval cancer: an alternative to exenteration?[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 917-925.
[9] Kelly Baillie, Nicholas Reed, Jennifer Laskey, Jiafeng Pan, Kimberley Kavanagh, Marion Bennie, Christine Crearie, Tanja Mueller, Azmat Sadozye, Rosie Harrand, Ashleigh Kerr, Kathryn Graham. Neoadjuvant chemotherapy in locally advanced cervical cancer: real-world data from the Cancer Medicines Outcomes Programme (CMOP)[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 926-935.
[10] Elif Eda Ozer, Melisa Bagci, Esengul Kocak Uzel, Gulsen Pinar Soydemir, Metin Figen, Meltem Kirli Bolukbas. Comparison of point a based plans with clinical target volume-based three-dimensional plans using dose—volume parameters in small lesion of cervical cancer brachyterapy[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 936-942.
[11] Polo Cornelisz Vermolen, Nienke E. van Trommel, Wouter V. Vogel, Judit A. Adam, Jacobus van der Velden, Constantijne H. Mom. The issue of false positive lymph nodes on [18F] FDG-PET/CT for cervical carcinoma and consequences for treatment[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 943-950.
[12] Jing Fang, Jinmei Fang, Ailin Wu, Yufei Zhao, Yun Liu. Clinical analysis of predisposing factors for radiation enteritis in patients with cervical cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 951-956.
[13] Danping Qian, Yin Zhu, Le Xu, Tingting Dong, Ting Chen, Zhenghong Yu. Icariin induces apoptosis in breast cancer MCF-7 cells by regulating the MELK mediated PI3K/AKT signaling pathway[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 957-965.
[14] Felix Chan, Cherynne Yuin Mun Johansson. Single-site robotic-assisted hysterectomy and sentinel lymph node mapping for low-risk endometrial cancer: surgical technique and preliminary outcomes[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 966-972.
[15] Priscila Thais Silva Mantoani, Daniela Rodrigues Siqueira, Millena Prata Jammal, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. Immune response in cervical intraepithelial neoplasms[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 973-981.
No Suggested Reading articles found!